RTX Has a $271 Billion Backlog. July 23 Is When It Has to Prove It.
Defense demand is undeniable. The margin story is what needs answering now.
Defense demand is undeniable. The margin story is what needs answering now.
The FDA ruling changed what PM can legally say about ZYN. Q2 earnings this morning will show if the market…
Coca-Cola's bull case is intact, but two major wildcards are about to get priced in.
The CFO already told you Q2 billing growth is running above a three-year high.
85% revenue growth and a Rule of 40 score of 145% meet the market's hardest question.
A rare disease dealmaker just bought its way into a new disease category with $5B in peak revenue potential.
The market is pricing in failure. The data is telling a different story.
An 86% EPS beat today just made insurance the most interesting trade in the market.
IBM's warning about enterprise cyber distraction just handed PANW its clearest catalyst yet.
A Meta nuclear PPA and record Q1 adjusted EBITDA are not yet in the price.